Cost-effectiveness analysis of hospital infection control response to an epidemic respiratory virus threat

Emerging Infectious Diseases

Volumn 15, Issue 12, 2009, Pages 1909-1916

  Dan, Yock Young ^a   Tambyah, Paul A ^a   Sim, Joe ^a   Lim, Jeremy ^b   Hsu, Li Yang ^a   Chow, Wai Leng ^b   Fisher, Dale A ^a   Wong, Yue Sie ^b   Ho, Khek Yu ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EPIDEMIC; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; PANDEMIC; PROBABILITY; SEVERE ACUTE RESPIRATORY SYNDROME; SIMULATION; SINGAPORE; SPANISH INFLUENZA; STOCHASTIC MODEL; TERTIARY HEALTH CARE; VIRUS VIRULENCE;

COST-BENEFIT ANALYSIS; CROSS INFECTION; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MARKOV CHAINS; SEVERE ACUTE RESPIRATORY SYNDROME; SINGAPORE;

EID: 73949088216     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1512.090902     Document Type: Article

References (23)

1. World Health Organization. Epidemic and pandemic alert and response (EPR) [cited 2009 Aug 29]. Available from http://www.who.int/csr/don/2009-08-28/en/ index.html
2. Hsu LY, Lee CC, Green JA, Ang B, Paton NI, Lee L, et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis. 2003;9:713-7.
3. Tambyah PA. Severe acute respiratory syndrome from the trenches, at a Singapore university hospital. Lancet Infect Dis. 2004;4:690-6. DOI: 10.1016/S1473-3099(04)01175-2
4. Leong HN, Chan KP, Oon LL, Koay ES, Ng LC, Lee MA, et al. Clinical and laboratory fi ndings of SARS in Singapore. Ann Acad Med Singapore. 2006;35:332-9.
5. Singapore Ministry of Health. Infl uenza pandemic plan [cited 2009 May 22]. Available from http://www.moh.gov.sg/mohcorp/uploadedFiles/News/Current- Issues/2007/Main%20Document%20 Public%20-Jan09.pdf
6. Blumenfeld HL, Kilbourne ED, Louria DB, Rogers DE. Studies on infl uenza in the pandemic of 1957-1958. I. An epidemiologic, clinical and serologic investigation of an intrahospital epidemic, with a note on vaccination effi cacy. J Clin Invest. 1959;38:199-212. DOI: 10.1172/JCI103789
7. Serwint J. Pediatrician-dependent barriers in infl uenza vaccine administration. Pediatr Infect Dis J. 1993;12:956-8.
8. Voirin N, Barret B, Metzger MH, Vanhems P. Hospital-acquired infl uenza: a synthesis using the Outbreak Reports and Intervention Studies of Nosocomial Infection (ORION) statement. J Hosp Infect. 2009;71:1-14. DOI: 10.1016/j.jhin.2008.08.013
9. Salgado CD, Farr BM, Hall KK, Hayden FG. Infl uenza in the acute hospital setting. Lancet Infect Dis. 2002;2:145-55. DOI: 10.1016/S1473-3099(02)00221-9
10. Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003;300:1966-70. DOI: 10.1126/ science.1086616
11. Vynnycky E, Trindall A, Mangtani P. Estimates of the reproduction numbers of Spanish infl uenza using morbidity data. Int J Epidemiol. 2007;36:881-9. DOI: 10.1093/ije/dym071
12. Seet RC, Lim EC, Oh VM, Ong BK, Goh KT, Fisher DA, et al. Readiness exercise to combat avian infl uenza. QJM. 2009;102:133-7. DOI: 10.1093/qjmed/hcn159
13. Novel Swine-Origin Infl uenza A (H1N1) Virus Investigation Team; Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin infl uenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-15.
14. Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic infl uenza. Nature. 2004;432:904-6. DOI: 10.1038/nature03063
15. Stilianakis NI, Perelson AS, Hayden FG. Emergence of drug resistance during an infl uenza epidemic: insights from a mathematical model. J Infect Dis. 1998;177:863-73.
16. Tan CC. SARS in Singapore - key lessons from an epidemic. Ann Acad Med Singapore. 2006;35:345-9.
17. Tan TT, Tan BH, Kurup A, Oon LL, Heng D, Thoe SY, et al. Atypical SARS and Escherichia coli bacteremia. Emerg Infect Dis. 2004;10:349-52.
18. Sim K, Chua HC. The psychological impact of SARS: a matter of heart and mind. CMAJ. 2004;170:811-2. DOI: 10.1503/cmaj. 1032003
19. Centers for Diseases Control and Prevention. Interim guidance for infection control for care of patients with confi rmed or suspected novel infl uenza A (H1N1) virus infection in a healthcare setting [cited 2009 May 25]. Available from http://www.cdc.gov/h1n1flu/ guidelines-infection-control.htm
20. Schull MJ, Stukel TA, Vermeulen MJ, Guttmann A, Zwarenstein M. Surge capacity associated with restrictions on nonurgent hospital utilization and expected admissions during an infl uenza pandemic: lessons from the Toronto severe acute respiratory syndrome outbreak. Acad Emerg Med. 2006;13:1228-31. DOI: 10.1111/j.1553-2712.2006.tb01653.x
21. Vaillant L, La Ruche G, Taratola A, Barboza P; Epidemic Intelligence Team at InVS. Epidemiology of fatal cases associated with pandemic H1N1 2009. Euro Surveill 2009;14:1-3.
22. Singapore Department of Statistics. Key annual indicators [cited 2009 Aug 28]. Available from http://www.singstat.gov.sg/stats/ keyind.html
23. Lim EC, Seet RC, Lee KH, Wilder-Smith EP, Chuah BY, Ong BK. Headaches and the N95 face-mask amongst healthcare providers. Acta Neurol Scand. 2006;113:199-202. DOI: 10.1111/j.1600-0404 .2005.00560.x